Scopis (Berlin) said Monday that it has established a presence in Cambridge, Massachusetts, with the help of the German government’s German Accelerator Life Sciences (GALS) program.
The company is already active in 50 countries around the world. It provides surgical navigation systems with AR in specialities including otorhinolaryngology, craniomaxillofacial, spine and neurosurgery.
Scopis’s next-generation Target-Guided Surgery Systems guide surgeons through AR-generated images overlaid onto the surgeon’s endoscope.
“We established a U.S. presence in Cambridge, Massachusetts, to make our disruptive technologies and solutions more readily available to patients and providers in the very important North American markets,” Scopis founder and CEO Bartosz Kosmecki said in a news release.
“The collaboration with GALS will accelerate our expansion into the U.S. market and help us establish further collaborations with U.S. companies and investors,” Kosmecki said.
The German Accelerator Life Sciences program is providing Scopis with a team of mentors and an industry network to leverage.
Augmented reality has become a hot area in surgery. Royal Philips, for example, recently announced an augmented reality approach to spinal surgery.
“Imaging technology should be an extension of a surgeon’s hands, allowing him or her to see where they want the technology to go and seamlessly move it there,” Ronald Tabaksblat, senior vice president and business leader at Philips’s Image Guided Therapy Systems, told MDO.
Touch Surgery, which already boasts a community of 1.5 million using its mobile surgical simulations, has meanwhile forged a partnership with DAQRI to add augmented reality capabilities to the simulations using DAQRI smart glasses.
[Want to stay more on top of MDO content? Subscribe to our weekly e-newsletter.]